Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Oct 31;24(1):1326.
doi: 10.1186/s12913-024-11679-5.

Cost-effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-COVID-19 condition after hospitalisation for COVID-19: the REGAIN RCT

Henry Nwankwo  1 , James Mason  2 , Martin Underwood  2   3 , Julie Bruce  2   3 , Ranjit Lall  2 , Chen Ji  2 , Mariam Ratna  2 , Gordon McGregor  2   3   4
Affiliations
Randomized Controlled Trial

Cost-effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-COVID-19 condition after hospitalisation for COVID-19: the REGAIN RCT

Henry Nwankwo et al. BMC Health Serv Res. .

Abstract

Background: Following the COVID-19 pandemic, millions of people continue to experience ongoing physical and mental health sequelae after recovery from acute infection. There is currently no specific treatment for the diverse symptoms associated with post-COVID-19 condition. Physical and mental health rehabilitation may help improve quality of life in such patients. This study reports the cost-effectiveness of a programme of physical and mental health rehabilitation compared to best practice usual care in people with post-COVID-19 condition who were previously hospitalised.

Methods: We conducted an economic evaluation within a randomised controlled trial from the perspective of the UK national health service (NHS) and personnel social services perspective (PSS). Resource used and health-related quality of life were collected using bespoke questionnaire and the EQ-5D-5 L questionnaire at three, six, and 12 months. Incremental costs and quality adjusted life years accrued over the follow-up period were estimated and reported as the incremental cost-effectiveness ratio. Estimate uncertainty was managed by multiple imputation and bootstrapping cost-effectiveness estimates; and displayed graphically on the cost-effectiveness plane.

Results: Over a 12-month time horizon, incremental costs and QALYs were £305 (95% CI: -123 to 732) and 0.026 (95% CI: -0.005 to 0.052) respectively. The ICER was £11,941 per QALY indicating cost-effective care. Sensitivity analyses supported the base case findings. The probability of the intervention being cost-effective at a £30,000 per QALY willingness-to-pay threshold was 84%.

Conclusion: The within-trial economic evaluation suggested that people with post-COVID-19 condition after hospitalisation should be offered a programme of physical and mental health rehabilitation as it likely reflects a cost-effective use of NHS resources. Hospitalisation for COVID-19 has become less commonplace: further evaluation in non-hospitalised patients may be worthwhile.

Trial registration: ISRCTN registry ISRCTN11466448 23rd November 2020.

Keywords: COVID-19; Cost-effectiveness analysis; Cost-utility analysis; Long COVID; Mental health rehabilitation; Physical rehabilitation; Post-COVID-19 condition; RCT; Randomised controlled trials; Rehabilitation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
NHS and PSS costs and EQ-5D-5 L utility estimates at each timepoint per trial group
Fig. 2
Fig. 2
Cost-effectiveness plane with 95% credible region
Fig. 3
Fig. 3
Cost-effectiveness acceptability curve
Fig. 4
Fig. 4
Net monetary benefit
Fig. 5
Fig. 5
Expected value of perfect and sampled information
See this image and copyright information in PMC

References

    1. Raveendran A, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metabolic Syndrome: Clin Res Reviews. 2021;15(3):869–75. - DOI - PMC - PubMed
    1. Davis HE, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133–46. - DOI - PMC - PubMed
    1. Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 30 March 2023. 2023 [cited 2024 14/02]; https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/....
    1. UK Health Security Agency. COVID-19 Hospital Activity. 2024. [cited 2024 05/09]. Available from: https://ukhsa-dashboard.data.gov.uk/topics/covid-19.
    1. Evans RA, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK Multicentre, prospective cohort study. Lancet Respiratory Med. 2021;9(11):1275–87. - DOI - PMC - PubMed

Publication types

LinkOut - more resources